CRISPR Therapeutics is pioneering a new class of medicines, to conduct the first company-sponsored clinical trial of a CRISPR gene-edited therapy.
Direct to consumer testing can potentially be quite dangerous without appropriate regulations and support to fully understand the implications of the information a consumer receives.
Those women at the highest risk of aggressive breast cancers may need a more personalised approach to treatment, rather than just mammograms.
GMI announces new cross-border research collaboration that aims to identify genetic markers, to help diagnose and treat Multiple Sclerosis (MS).
Nobel Laureate who won the 2009 Nobel Prize in Medicine for his work on telomere retracts his own paper in ‘definitely embarrassing’ science fail.
Companion diagnostic test for multiple cancers wins approval from both the FDA and CMS.
As the year draws to a close, Rick Duprey, writing for The Motley Fool, takes a look back at three biotechs that have quadrupled this year.
Christmas shoppers in search of a thoughtful gift that “is personal and says a lot” about the recipient may have just outdone themselves.
University that employed a controversial herpes vaccine researcher says it learned about his illegal experimentation on human subjects, last summer.
Recent studies have started to shed new light on how wrong assumptions are about the relationship between race and skin colour.
With 2017 coming to a close, the biopharma industry and the US Food and Drug Administration (FDA) are preparing to face a very busy time.
A recent study sheds new light on maternal asthma, suggesting that during pregnancy it may be caused due to changes in an infant’s gut microbes.
Scientists have successfully created a biohybrid robot that has the potential to carry drugs to specific parts of the body, minimising side effects.
Although DNA-home testing is getting a lot more accessible for the everyday person, Senator Chuck Schumer claims doing so is more dangerous than we think.
Last month, Tristan Roberts became the first human to inject himself with an untested, experimental gene therapy, live on Facebook.